Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Ruan

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|June 25, 2014
Adrenocortical carcinoma: the management of metastatic diseaseAndré P Fay, Aymen Elfiky, Gabriela H Teló, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2010
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancerChi-Iou Lin, Jinyan Du, Wen T Shen, et al.
Hypertension (Dallas, Tex. : 1979)|November 6, 2013
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormoneJenifer M Brown, Jonathan S Williams, James M Luther, et al.
Surgery|December 6, 2011
Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activityChi-Iou Lin, Justine A Barletta, Matthew A Nehs, et al.
Molecular Cancer Research : MCR|October 15, 2009
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancerChi-Iou Lin, Edward E Whang, David B Donner, et al.
Surgery|December 2, 2008
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancersDaniel T Ruan, Robert S Warren, Jacob Moalem, et al.
Nature Immunology|December 24, 2013
CD1a-autoreactive T cells recognize natural skin oils that function as headless antigensAnnemieke de Jong, Tan-Yun Cheng, Shouxiong Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancerKshama R Mehta, Kentaro Nakao, Marlene B Zuraek, et al.
Journal of the American College of Surgeons|December 27, 2016
Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid CancerMichael C Sullivan, Paul H Graham, Erik K Alexander, et al.
Cancer Discovery|April 18, 2015
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at EndosomesChen Li Chew, Andrea Lunardi, Federico Gulluni, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|June 25, 2014
Adrenocortical carcinoma: the management of metastatic diseaseAndré P Fay, Aymen Elfiky, Gabriela H Teló, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2010
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancerChi-Iou Lin, Jinyan Du, Wen T Shen, et al.
Hypertension (Dallas, Tex. : 1979)|November 6, 2013
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormoneJenifer M Brown, Jonathan S Williams, James M Luther, et al.
Surgery|December 6, 2011
Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activityChi-Iou Lin, Justine A Barletta, Matthew A Nehs, et al.
Molecular Cancer Research : MCR|October 15, 2009
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancerChi-Iou Lin, Edward E Whang, David B Donner, et al.
Surgery|December 2, 2008
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancersDaniel T Ruan, Robert S Warren, Jacob Moalem, et al.
Nature Immunology|December 24, 2013
CD1a-autoreactive T cells recognize natural skin oils that function as headless antigensAnnemieke de Jong, Tan-Yun Cheng, Shouxiong Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancerKshama R Mehta, Kentaro Nakao, Marlene B Zuraek, et al.
Journal of the American College of Surgeons|December 27, 2016
Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid CancerMichael C Sullivan, Paul H Graham, Erik K Alexander, et al.
Cancer Discovery|April 18, 2015
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at EndosomesChen Li Chew, Andrea Lunardi, Federico Gulluni, et al.
Pageof 6